NanoValent Pharmaceuticals has a strong and extensive IP asset portfolio, covering its various development activities. This overview includes a select number of issued patents.
2022
Publication/Patent Number
US11337924B2
Targeted polymerized nanoparticles for cancer treatment
2020
Publication/Patent Number
WO2020118271A1
Fibrin-targeted polymerized shell lipid microbubbles
2020
Publication/Patent Number
AU2015240766B2
Fibrin-targeted polymerized shell lipid microbubbles
2019
Publication/Patent Number
US10369104B2
Targeted polymerized nanoparticles for cancer treatment
2018
Publication/Patent Number
US9956176B2
Compositions and methods for treating ewing sarcoma
2011
Publication/Patent Number
WO2011149985A1
Polymerized shell lipid microbubbles and uses thereof